Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
To identify drug patent expiration dates for pharmaceutical companies
— Investment analyst, USA
To find manufacturing process of specific drugs
— Chemist, India
For drug patent information
— Pharmaceutical business developer, USA
To obtain drug patent expiration dates for Switzerland
— Patent attorney, Switzerland
For paragraph IV challenge research
— Pharmaceutical company, USA
Generated: May 24, 2017
| Patents: | 21 |
| Tradenames: | 6 |
| Ingredients: | 5 |
| NDAs: | 6 |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cubist Pharms Llc | SIVEXTRO | tedizolid phosphate | POWDER;IV (INFUSION) | 205436-001 | Jun 20, 2014 | RX | Yes | Yes | 8,420,676 | ► Subscribe | Y | Y | ► Subscribe | ||||||||||||||||
Cubist Pharms Llc | SIVEXTRO | tedizolid phosphate | POWDER;IV (INFUSION) | 205436-001 | Jun 20, 2014 | RX | Yes | Yes | ► Subscribe | ► Subscribe | |||||||||||||||||||
Cubist Pharms Llc | ZERBAXA | ceftolozane sulfate; tazobactam sodium | POWDER;IV (INFUSION) | 206829-001 | Dec 19, 2014 | RX | Yes | Yes | 8,968,753 | ► Subscribe | ► Subscribe | ||||||||||||||||||
Cubist Pharms Llc | ZERBAXA | ceftolozane sulfate; tazobactam sodium | POWDER;IV (INFUSION) | 206829-001 | Dec 19, 2014 | RX | Yes | Yes | 7,129,232 | ► Subscribe | Y | Y | ► Subscribe | ||||||||||||||||
Cubist Pharms Llc | ZERBAXA | ceftolozane sulfate; tazobactam sodium | POWDER;IV (INFUSION) | 206829-001 | Dec 19, 2014 | RX | Yes | Yes | 8,906,898 | ► Subscribe | Y | Y | ► Subscribe | ||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
For a comprehensive list of patents, along with their details, for some drug molecules
— Business analyst, India
To be informed abut patent protection and patent challenges
— Business development / Licensing / Marketing & sales, Italy
To apply for a patent
— Pharmaceutical researcher, USA
To get information on expired patents
— Patent Attorney, USA
To find drug patent expirations in the North Africa market
— Business development, India
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
